Monoclate-P Articles

US COMPANIES IN BIOTECH LINK-UP

18 January 1993

SYNERGEN, SELECTIDE R&D COLLABORATION

18 January 1993

INTERPHARM LABS 41% SALES BOOST

4 January 1993

SOMATOGEN PROMOTION

4 January 1993

HOECHST BUILDS US NEURO CENTER

4 January 1993

GENZYME GENE THERAPY APPROVAL

4 January 1993

ISRAELI APPROVAL FOR BTG

4 January 1993

ISRAEL CONSIDERS KORATH INCLUSIONS

4 January 1993

RECOMBINATE APPROVAL IN USA

21 December 1992

MEDEVA ACQUIRES HEPATITIS A VACCINE

21 December 1992

GENENTECH AWARDED US NGF PATENT

14 December 1992

KABI AND FACTOR VIII

14 December 1992

REPLIGEN AWARDED PROTEIN A PATENT

14 December 1992

EURO OSTEOPOROSIS MARKET TO BOOM?

14 December 1992

GENENTECH DNase STUDY COMPLETED

7 December 1992

BOEH-INGELHEIM'S IMMUKIN LAUNCHED IN UK

7 December 1992

IN DEFENSE OF BIOTECHNOLOGY

7 December 1992

US CHEMICAL/PHARMA COS' POOR PERFORMANCE

9 November 1992

FUJISAWA'S PROMISING R&D PIPELINE

9 November 1992

DRUG COMPANIES FAILING TO TARGET MALARIA?

9 November 1992

RHONE-POULENC RORER NET INCOME UP 13.4%

2 November 1992

JAPAN: NDA FILED FOR NARTOGRASTIM

12 October 1992

FIRST BIRTH USING SERONO'S r-hFSH

12 October 1992

FOCUS ON IVAX PRODUCT PIPELINE

12 October 1992

GENENTECH, UNIVAX LINK FOR AIDS R&D

5 October 1992

SUCCESSFUL COMPLETION OF SOMATOGEN OFFERING

7 September 1992

VERDICT IN CNTF PATENT DISPUTE

7 September 1992

USE OF GROWTH FACTORS IN AIDS MANAGEMENT

7 September 1992

ENZON EXPANDS R&D AGREEMENTS

3 August 1992

FURTHER INDICATION FOR INTRON A

3 August 1992

GENZYME BUYS BACK NEOZYME PROGRAMS

3 August 1992

GOOD GROWTH FOR US COMPANIESCONTINUES FOR US COs

3 August 1992

NEW DRUGS HIGHLIGHTED AT AIDS CONFERENCE

3 August 1992

SYNENGEN READY FOR FUTURE

3 August 1992

TOYOBO CALLS HALT TO t-PA SALES

6 July 1992

ISRAEL'S BTG MOVES NEARER TO PROFITABILITY

6 July 1992

DEVELOPMENTS AT SOMATOGEN

6 July 1992

Kabi's Laron's Syndrome Treatment

29 June 1992

rIGF-1 AND LARON-TYPE DWARFISM

1 June 1992

GENENTECH'S HUMAN HER-2 ENTERS PHASE I

1 June 1992

FRONE BOOSTS SALES AT INTERPHARM IN 91

1 June 1992

AMGEN/CHUGAI PATENT DISPUTE RESOLVED

25 May 1992

SERAGEN EXPANDS IL-2 STUDIES

25 May 1992

SERONO ACHIEVES IVF SUCCESS WITH rhFSH

18 May 1992

GENENTECH'S EXPANDING PRODUCT PORTFOLIO

11 May 1992

CHIRON'S IL-2 APPROVED IN USA

11 May 1992

REGENERON BEGINS CNTF TRIALS

11 May 1992

GENENTECH'S DNase EFFECTIVE IN CF

11 May 1992

SWEDEN'S PHARMA MARKET IN 1991

11 May 1992

CONNAUGHT'S VACCINE RESEARCH PROGRAM

11 May 1992

REVENUES DECLINE, R&D UP AT SCIOS IN 1991

4 May 1992

BTG'S rhGH APPROVED IN FRANCE

27 April 1992

PROJECT REVIEW FROM NOVO NORDISK

27 April 1992

CANADA APPROVES INTERFERON ALFA

27 April 1992

BULLETIN REViEWS EPOETIN

20 April 1992

US PATENT GRANTED FOR INHIBIN

20 April 1992

CANGENE CANCER DRUG IN TRIALS?

20 April 1992

NOVO-NORDISK'S rec INSULIN LAUNCHED IN FRANCE

13 April 1992

GENZYME SEEKING EURO APPROVAL OF CEREDASE

13 April 1992

EPO AND HISTAMINE

13 April 1992

NOVO-NORDISK'S rec INSULIN LAUNCHED IN FRANCE

13 April 1992

FUTURE PRODUCTS FROM GENETICS INSTITUTE

6 April 1992

WORLD MARKET FOR BIO-DRUGS

6 April 1992

AUSTRALIAN VACCINE RESEARCH

6 April 1992

CHUGAI'S EPOCH

6 April 1992

AUSTRALIAN VACCINE RESEARCH

6 April 1992

CHUGAI'S EPOCH

6 April 1992

WORLD MARKET FOR BIO-DRUGS

6 April 1992

FUTURE PRODUCTS FROM GENETICS INSTITUTE

6 April 1992

HOECHST ON DRUG DEV'T ECONOMIC PRESSURES

23 March 1992

US APPRO OF J&J's HEP C TEST

23 March 1992

SOMATOGEN'S rhB1.1 BLOOD SUBSTITUTE

23 March 1992

GENENTECH'S DNase IN CYSTIC FIBROSIS

23 March 1992

ROFERON-A COULD SAVE SIGHT

16 March 1992

REPLIGEN'S rPF4

16 March 1992

US BIOTECH, C-R MARKET FORECASTS

16 March 1992

JAPAN URGES IL-2 AND PKU DRUG APPROVAL

9 March 1992

INTERPHARM AND rIL-6

9 March 1992

REPLIGEN R&D PARTNERSHIP

9 March 1992

SHIONOGI LAUNCHES HUMULIN U IN JAPAN

3 February 1992

ISRAELI HEPATITIS VACCINATION PLAN

27 January 1992

PRODUCT DEVELOPMENTS FROM ISRAEL'S BTG

27 January 1992

GENENTECH TO START TRIALS OF HER-2

27 January 1992

SUCCESS CLAIMED FOR RABIES VACCINE

20 January 1992

HOME LAUNCH FOR BIOSIDUS' BIOFERON

20 January 1992

THIRD QTR SALES UP AT INTERPHARM

13 January 1992

UK PATENT FOR SOMATOGEN'S rHb

13 January 1992

NEW PLANT FOR GENZYME CORP

13 January 1992

IMMUNEX COULD CAPTURE GM-CSF/IL-3 MARKET

6 January 1992

CIBA-GEIGY MOVES BIOTECH TO FRANCE

6 January 1992

FDA SET TO APPROVE MILES' KOGENATE

6 January 1992

Novo Nordisk ups 2008 guidance